Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.5K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.4K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.4K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

837
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
837
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

1.2K
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
1.2K
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

1.8K
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
1.8K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

613
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
613

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analytical Sensitivity and HER2-Low: To Measure or Not to Measure, That Is the Question.

Laboratory investigation; a journal of technical methods and pathology·2026
Same author

Differences in T-cell Densities and Neighborhood Patterns in Human Colorectal Adenomas and Sessile Serrated Lesions.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Differences in T-cell counts and neighborhood patterns in human colorectal adenomas and sessile serrated lesions.

bioRxiv : the preprint server for biology·2026
Same author

Tissue gene expression analysis approach in a context of high technical and biological heterogeneity.

BMC research notes·2025
Same author

Tissue gene expression analysis approach in a context of high technical and biological heterogeneity.

Research square·2025
Same author

Clinical Applications of Bone Marrow CD34 Immunohistochemistry (BM CD34 IHC) Assay: International Council for Standardization in Hematology (ICSH) Guidelines.

International journal of laboratory hematology·2024
Same journal

How important is fiber in the Crohn's disease story?

Gastroenterology·2026
Same journal

Reply to "Critical Appraisal of the Integrin αV-YAP-CTGF Axis in Congestive Hepatopathy".

Gastroenterology·2026
Same journal

Critical Appraisal of the Integrin αV-YAP-CTGF Axis in Congestive Hepatopathy.

Gastroenterology·2026
Same journal

A High-Risk Impaction: To Scope or to Stent First?

Gastroenterology·2026
Same journal

Epithelial FOXP3 Orchestrates O-Glycosylated IL6 Secretion to Drive Pancreatic Fibrocarcinogenesis.

Gastroenterology·2026
Same journal

Reply.

Gastroenterology·2026
See all related articles

Related Experiment Video

Updated: Mar 28, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K

Increased Risk of Colorectal Cancer Development Among Patients With Serrated Polyps.

Rune Erichsen1, John A Baron2, Stephen J Hamilton-Dutoit3

  • 1Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus N, Denmark.

Gastroenterology
|December 19, 2015
PubMed
Summary
This summary is machine-generated.

Sessile serrated adenomas/polyps (SSA/Ps) and traditional serrated adenomas (TSAs) significantly increase colorectal cancer (CRC) risk, similar to or exceeding conventional adenomas. Early detection and management of these serrated polyps are crucial for CRC prevention.

Keywords:
Colorectal NeoplasmEarly DetectionRisk FactorTumor

More Related Videos

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

7.5K
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.8K

Related Experiment Videos

Last Updated: Mar 28, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K
Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

7.5K
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.8K

Area of Science:

  • Gastroenterology
  • Oncology
  • Pathology

Background:

  • Sessile serrated adenomas/polyps (SSA/Ps) and traditional serrated adenomas (TSAs) are recognized colorectal cancer (CRC) precursors.
  • Distinguishing serrated polyps from hyperplastic polyps is critical for risk assessment.

Purpose of the Study:

  • To investigate the association between serrated polyps (SSA/Ps and TSAs) and the risk of developing colorectal cancer (CRC).
  • To compare the CRC risk posed by serrated polyps with that of conventional adenomas and hyperplastic polyps.

Main Methods:

  • A nationwide population-based, case-control study using Danish databases (1977-2009) involving 272,342 individuals who underwent colonoscopies.
  • Identification and pathological review of colorectal polyps from 2045 CRC cases and 8105 controls.
  • Logistic regression analysis to calculate odds ratios (ORs) for CRC risk associated with different polyp types.

Main Results:

  • SSA/Ps were associated with a 3.07-fold increased CRC risk (OR, 3.07; 95% CI, 2.30-4.10), with higher risk for women and polyps proximal to the splenic flexure.
  • SSA/Ps with dysplasia showed a significantly elevated CRC risk (OR, 4.76; 95% CI, 2.59-8.73).
  • TSAs demonstrated a substantial CRC risk (OR, 4.84; 95% CI, 2.36-9.93), comparable to conventional adenomas (OR, 2.51; 95% CI, 2.25-2.80). Hyperplastic polyps showed a minimal association with CRC risk (OR, 1.30; 95% CI, 0.96-1.77).

Conclusions:

  • Patients with SSA/P or TSA face an elevated risk of colorectal cancer.
  • The CRC risk associated with SSA/P and TSA is comparable to or greater than that associated with conventional adenomas.
  • These findings underscore the importance of recognizing and managing serrated polyps as significant precursors to CRC.